Investor PresentationOctober 2020

CHANGING THE WAY THE WORLD SEES SANITIZATION

This presentation includes “forward-looking statements” within the meaning of the safe harborprovisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements arebased upon the current beliefs and expectations of APHEX’s management and are subject tosignificant risks and uncertainties. There can be no guarantees with respect to pipelineproducts that the products will receive the necessary regulatory approvals or that they willprove to be commercially successful. If underlying assumptions prove inaccurate or risks oruncertainties materialize, actual results may differ materially from those set forth in theforward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions andcompetition; general economic factors, including interest rate and currency exchange ratefluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in theUnited States and internationally; global trends toward healthcare cost containment;technological advances, new products and patents attained by competitors; challengesinherent in new product development, including obtaining regulatory approval; APHEX’s abilityto accurately predict future market conditions; manufacturing difficulties or delays; financialinstability of international economies and sovereign risk; dependence on the effectiveness ofAPHEX’s patents and other protections for innovative products; and the exposure to litigation,including patent litigation, and/or regulatory actions.

APHEX undertakes no obligation to publicly update any forward-looking statement, whether asa result of new information, future events or otherwise. Additional factors that could causeresults to differ materially from those described in the forward-looking statements can befound in APHEX’s 2018 Annual Report on Form 10-K and the company’s other filings with theSecurities and Exchange Commission (SEC) available at the SEC’s website (www.sec.gov).

SAFE HARBOR

Aphex BioCleanse Systems, Inc is the developer of the world’s first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology. The technology, called Hy-IQ® Water, has a unique method of action that uses hydrogen ions traveling close to the speed of light to breach the cell walls of exoskeleton germs. Preliminary research has proven that it is more effective in killing pathogens than alcohol-based solutions and the company is currently seeking FDA-approval to become the first federally-approved hand sanitizer.

ABOUT APHEX BIOCLEANSE SYSTEMS

2010Founded

APHEX was one of the first companies to

identify disadvantages to traditional sanitation

products that use harsh chemicals

Breakthrough in water-based, sanitation using physics rather than chemistry.

Develops world’s first Hy-IQ® sanitation

product – a hand wash

Registers for EPA & FDA registration of Hy-IQ®

as an ingredient

Signs international distribution

agreements, surpasses 100k gallons sold

Establishes prototype lab to develop non-chemical

sanitation solution

Develops and releases five other Hy-IQ® -based

sanitation products

Reverse merger with Sunset Capital, Trades

on the OTCMarkets

HISTORY OF APHEX BIOCLEANSE SYSTEMS

Files Patent on Hy-IQ®

2008 2009 2010 2011 2015 2019 2020

With headquarters in Rochester, New York and a manufacturing facility in Port Richey, Florida,Aphex BioCleanse Systems, Inc. is positioned to service both our U.S. and Canadiancustomers quickly and efficiently. Our European partners “Aphex Europe” sell our Americanmade products in that part of the world, giving us an international presence.

Our mission is to save lives, ease the burden of illness, increase workforce productivity, and ingeneral, make the world a healthier and safer place, by providing the most effective and safestsanitizing solutions available. We are dedicated to making every one of our products in theUnited States of America and making sure that those products are truly environmentally-friendly. We are committed to making Aphex BioCleanse Systems, Inc. the new benchmark ineffective green technologies.

OUR REACH

OUR MISSION

Our diversified product portfolio targets some of the largest consumer trend markets in the world with an unmatched technological breakthrough.

We are positioned to capitalize on the largest mainstream shift in hygiene history!

CAPITALIZING ON THE LARGEST GROWTH TRENDS

Global Market Hand Sanitizer

Hard Surface Disinfectant

Fruit & Vegetable Wash Wound Care General Hand

Wash

DemographicGeneral

AudiencesResidential & Commercial Agriculture Heathcare General

Audiences

Market Size in $USD*

Aphex Brand(s) DermAphex SanAphex VegAphex MedAphex DermAphex

$1.87Billion

(2020)SOURCE

Fortune Business Insight

$30.11Billion

(2027)SOURCE

Reports and Data

$783.6Million

(2019)SOURCE

Extensive Research

$7.7Billion

(2025)SOURCE

Arizton Advisory & Intelligence

$10.73Billion

(2027)SOURCE

Grandview Research

*unless otherwise noted

INDUSTRY OVERVIEW

The majority of sanitization products use chemicals such as alcohol or chlorine to kill pathogens. While these chemicals can be effective, they come with major disadvantages such as:

• Many pathogens, germs and bacteria are building a resistance to these chemicals

• These chemicals are extremely dangerous if ingested or applied in high doses

• Alcohol is extremely flammable, making production dangerous

• With consistent use, chemicals can dry out the skin

• These chemicals have a terrible odor and can dye clothing and other materials

THE PROBLEM

Alcohol-free. Non-irritating.

Hypoallergenic. Scent-free.

Child-safe. Non-flammable.

Prevents the transfer of germs.

BENEFIT OVERVIEW

THE SOLUTION

NORTH CAROLINA STATE UNIVERSITY STUDY SHOWS HY-IQ’S ABILITY TO SERVE AS SAFE AND EFFECTIVE SANITIZATION ALTERNATIVE

Current sterilization methods commonly used to sanitize chicken eggs utilize harsh chemicalsthat can be harmful to the body if ingested. Due to restraints on how much of these chemicalproducts can safely be added to eggs, their shelf life is greatly diminished.

THE PROBLEM

THE SOLUTIONThrough a study conducted by the esteemed North Carolina State University, Hy-IQ® wasproven as a non-toxic and effective solution to this problem. In addition to serving as a safesterilizing alternative, eggs sanitized with Hy-IQ® lasted several days longer in-store than thosesanitized with chemical solutions.

Hy-IQ® continues to show its versatility across many industries as a safe, non-alcoholic, non-toxic sanitization solution.

PRODUCTS

SanAphex® is based on a water-basedtechnology designed to effectively kill 99.9%of germs without the side effects of alcohol.Powered by Hy-IQ® Water, SanAphex® continuesto kill germs hours after drying.

SanAphex® uses a variation of Hy-IQ to kill 99% ofpathogens/germs on surfaces in 30 seconds to oneminute. It is scent-free and is non-flammable. It is beingused in hospitals, restaurants, schools and in-home today.

APHEX PRODUCT LINE

APHEX PRODUCT LINE

DermAphex® is a foaming water-based handsanitizer designed to effectively kill 99.9% ofgerms without the side effects of alcohol.Powered by Hy-IQ® Water, DermAphex® continuesto kill germs hours after drying.

DermAphex ® is a hand sanitizing solution that meets the requirements of the European EN-1500 standard.

MedAphex® provides effective germ-killing for cuts, scrapes,and wounds. Painless and effective water-based technologydesigned to effectively kills 99.9% of germs without the sideeffects of alcohol. Powered by Hy-IQ® Water, MedAphex®

continues to kill germs hours after drying.

A revolutionary wound wash that does not sting, stain, dry orirritate skin or open wound beds! MedAphex® is a no-rinseformula that kills 99.9% of germs and continues killinggerms for hours.

MedAphex® allows first responders and health careproviders to painlessly treat lacerations and sores quicklyand effectively.

APHEX PRODUCT LINE

APHEX PRODUCT LINE

VegAphex® Fruit and Vegetable Wash can beused on all fruits and vegetables. It is organicand safe for everyday use with the ionizedwater-based formula is effective and safe forhuman consumption.

VegAphex® Fruit and Vegetable Wash is organic and can be used everyday on all produce. It is safe for human consumption.

Additional Products in Development

• HydrAphex® is one of the company’s flagship products. It is a child-safe foaming water-based hand sanitizer that helps you prevent the transfer of germs that has been proven in testing to not damage or dry out your skin.

• VetAphex® is a wound wash for pets that is pain free, easy to apply and a welcome relief for “hot spots” on dogs and cats. The solution has also been proven to kill ear mites in the first application.

• BugAphex is an organic solution that when applied to fruit and vegetable plants will instantly kill any hairy aphids or similar pests feeding on the leaves, etc.

Additional Potential Focus Areas of Hy-IQ® Technology:

• Therapeutics • Mass gathering sanitization

APHEX PRODUCT LINE

State-of-the-art Production Facility in Port Richey, FL

• 9600 sq. ft. of production space

• Ability to produce 90 totes per day including ready to use (RTU) solution and up to 10X concentrate solutions

• Research & development capacity

• Scalable space in order to meet increased demand

FACILITY

Aphex works with certified testing organizations such as BioScience Laboratories, Inc., Biological Consulting Services of North Florida, Inc, and Consumer Products Testing Co. to ensure the safety and efficacy of all of its products.

The Company has tested its surface and hand sanitizer products against:

PRODUCT TESTING AND REGISTRATION

• E.coli• Coronavirus• H1N1 Influenza A• MRSA• Rhinovirus 39

• Candida Auris• Clostridium Difficile• Klebsiella Pneumoniae• Bacteriophage PRD-1• Trichophyton Mentagrophytes

In addition, Aphex has completed a test with North Carolina State University to improve poultry yield.

• When eggs were washed with a product containing Hy-IQ®, the eggs lasted over two weeks longer on store shelves and any E.coli and salmonella present were removed.Note: Eggs are currently unwashed today due to contaminants of chemicals

PRODUCT PARTNER DISCOVERY PRE-CLINICAL PHASE 1 FDA

APPROVALEPA

APPROVAL

HydrAphex®

Hand Sanitizer dinical Trial In Accordance with Safety and Efficacy of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use. Final Rule

DermAphex®Biological Consulting Services of North Florida, Inc.

- MRSA: Antibacterial Efficacy Study- Influenza A (HlNl) Antiviral Efficacy Study- Rhinovirus 39: Antiviral Efficacy Study- dostridium Difficile: Antibacterial Efficacy Study- Klebsiella Pneumoniae: Antimicrobial Efficacy Study- Bacteriophage PRD-1: Antiviral Efficacy Study- E.coli: Antimicrobial Efficacy Study

Consumer Product Testing Co.

Hy-IQ® BioScienceLaboratories, Inc.

Skin Reaction Test: EpiOcular™ TissueModel In Vitro Toxicity Testing System

Biological Consulting Services of North Aorida, Inc.

Trichophyton Mentagrophytes: Prep-It Solution

SANITIZATION PRODUCT PIPELINE

GRAS-Certified

David WeaverPresident/CEODavid Weaver holds over 40 years of experience in engineering and designand is responsible for the creation of much of Aphex’s proprietary formulas.Previously, he spent over two decades as an optical engineer for EastmanKodak, where he earned a name for himself by streamlining the company’stechnology and operations, training its team around the world andinnovating for the photography industry. Following his role with EastmanKodak, Weaver went on to found his own digital camera company, where heled the company to sell over $100 million within the first year through hisinnovations. He also helped Motorola launch the first-ever camera phone. AtAphex, Weaver brings his innovative mindset, passion for disrupting thestatus quo and entrepreneurial spirit to the team.

David OlundExecutive Vice-PresidentDavid Olund, Executive Vice President of Aphex, has found his niche inleading publicly-traded pharmaceutical companies to success. During his40-year career in finance, Olund has consulted for multinationalcorporations, created financial products and helped take them tomarket and spent over a decade guiding OTC-traded pharmaceuticalcompanies. He was chosen to serve as a regional financial consultant forLeiman American Express at just 23 years old and founded his ownboutique financial planning firm at 24. In more recent years, David hasconsulted for Universal Administration Corp and Zapvir, Inc. At Aphex,Olund guides the company’s financial strategy, including executing itsfinancing plan and merger and leads Aphex’s business development.

PROVEN MANAGEMENT TEAM

Jeanne Moldenhauer Lead Regulatory ConsultantJeanne Moldenhauer has been a lead consultant for Aphex BioCleanseSystems for since 2019. She is a sought-after pharmaceutical, biotech, anddevice consultant who has dedicated over 25 years to the industry.Moldenhauer’s areas of expertise include regulatory affairs, qualityassurance, regulatory compliance, quality compliance, risk management,sterility assurance, sterilization, aseptic processing, validation, softwarevalidation, microbiology, environmental monitoring, alternative methods,process analytical technology, PAT, HACCP, contamination control,compounding pharmacy microbiology and regulatory issues.

PROVEN MANAGEMENT TEAM

US Patent 9204633Using an unsubstituted quatenary ammonium salt composition with other ingredients as a skin sanitizing solution and natural skin conditionerThis invention relates to the use of Hy-IQ in products

US Patent 10039696Highly protonated hydronium and peroxymonosulfuric acid as a sanitizing solutionThis invention relates to using highly protonated hydronium and peroxymonosulfuric acid as a sanitizing solution.

INTELLECTUAL PROPERTY

North American Address:15 Fishers Rd. Suite 111

Pittsford, NY 14534

For further information, please contact:Tel. +1 585 798-7775info@aphexus.comwww. aphexus.com